פריוריקס טטרה
Country: Իսրայել
language: եբրայերեն
source: Ministry of Health
documentation_request_send
active_ingredient:
LIVE ATTENUATED MEASLES VIRUS; LIVE ATTENUATED MUMPS VIRUS; LIVE ATTENUATED RUBELLA VIRUS; LIVE ATTENUATED VARICELLA VIRUS
MAH:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC_code:
J07BD54
pharmaceutical_form:
אבקה וממס להכנת תמיסה להזרקה
composition:
LIVE ATTENUATED MEASLES VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED MUMPS VIRUS 10^ 4.4 CCID50; LIVE ATTENUATED RUBELLA VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED VARICELLA VIRUS 10^ 3.3 PFU
administration_route:
תת-עורי
prescription_type:
מרשם נדרש
manufactured_by:
GLAXO SMITH KLINE BIOLOGICALS S.A
therapeutic_group:
MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED
therapeutic_area:
MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED
therapeutic_indication:
Priorix-Tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.
authorization_date:
2023-07-31
